Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
20
pubmed:dateCreated
2001-5-15
pubmed:abstractText
Human complement receptor type 2 (CR2, CD21) is a cell surface receptor that binds three distinct ligands (complement C3d, Epstein-Barr virus gp350/220, and the low-affinity IgE receptor CD23) via the N-terminal two of fifteen or sixteen short consensus/complement repeat (SCR) domains. Here, we report biophysical studies of the CR2 SCR 1-2 domain binding to its ligand C3dg. Two recombinant forms of CR2 containing the SCR 1-2 and SCR 1-15 domains were expressed in high yield in Pichia pastoris and baculovirus, respectively. Circular dichroism spectroscopy showed that CR2 SCR 1-2 receptor possessed a beta-sheet secondary structure with a melting temperature of 59 degrees C. Using surface plasmon resonance, kinetic parameters for the binding of either CR2 SCR 1-2 or the full-length SCR 1-15 form of CR2 showed that the affinity of binding to immobilized C3d is comparable for the SCR 1-15 compared to the SCR 1-2 form of CR2. Unexpectedly, both the association and dissociation rates for the SCR 1-15 form were slower than for the SCR 1-2 form. These data show that the SCR 1-2 domains account for the primary C3dg binding site of CR2 and that the additional SCR domains of full-length CR2 influence the ability of CR2 SCR 1-2 to interact with its ligand. Studies of the pH and ionic strength dependence of the interaction between SCR 1-2 and C3d by surface plasmon resonance showed that this is influenced by charged interactions, possibly involving the sole His residue in CR2 SCR 1-2. Sedimentation equilibrium studies of CR2 SCR 1-2 gave molecular weights of 17 000, in good agreement with its sequence-derived molecular weight to show that this was monomeric. Its sedimentation coefficient was determined to be 1.36 S. The complex with C3d gave molecular weights in 50 mM and 200 mM NaCl buffer that agreed closely with its sequence-derived molecular weight of 50 600 and showed that a 1:1 complex had been formed. Molecular graphics views of homology models for the separate CR2 SCR 1 and SCR 2 domains showed that both SCR domains exhibited a distribution of charged groups throughout its surface. The single His residue is located near a long eight-residue linker between the two SCR domains and may influence the linker conformation and the association of C3d and CR2 SCR 1-2 into their complex. Sedimentation modeling showed that the arrangement of the two SCR domains in CR2 SCR 1-2 is highly extended in solution.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0006-2960
pubmed:author
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5931-41
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:11352728-Amino Acid Sequence, pubmed-meshheading:11352728-Binding, Competitive, pubmed-meshheading:11352728-Cloning, Molecular, pubmed-meshheading:11352728-Complement C3b, pubmed-meshheading:11352728-Computer Simulation, pubmed-meshheading:11352728-Consensus Sequence, pubmed-meshheading:11352728-Humans, pubmed-meshheading:11352728-Ligands, pubmed-meshheading:11352728-Models, Molecular, pubmed-meshheading:11352728-Molecular Sequence Data, pubmed-meshheading:11352728-Peptide Fragments, pubmed-meshheading:11352728-Pichia, pubmed-meshheading:11352728-Protein Binding, pubmed-meshheading:11352728-Receptors, Complement 3d, pubmed-meshheading:11352728-Recombinant Proteins, pubmed-meshheading:11352728-Repetitive Sequences, Amino Acid, pubmed-meshheading:11352728-Sequence Alignment, pubmed-meshheading:11352728-Solutions, pubmed-meshheading:11352728-Spectrometry, Mass, Matrix-Assisted Laser..., pubmed-meshheading:11352728-Structure-Activity Relationship, pubmed-meshheading:11352728-Surface Plasmon Resonance, pubmed-meshheading:11352728-Ultracentrifugation
pubmed:year
2001
pubmed:articleTitle
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
pubmed:affiliation
Department of Medicine, Division of Rheumatology, University of Colorado Health Sciences Center, Denver, Colorado 80262, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't